| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
5623.4 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
6309.6 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
13230.9 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
56234.1 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
166670.0 |
nM |
None |
| Bos taurus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Bos taurus |
Monoamine oxidase B |
Activity |
nan |
None |
10.1021/jm800656v |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Canis lupus familiaris |
Canis familiaris |
Change |
-10.0 |
% |
10.1021/jm00391a026 |
| Canis lupus familiaris |
Canis familiaris |
Change |
-9.0 |
% |
10.1021/jm00383a006 |
| Canis lupus familiaris |
Canis familiaris |
Change |
9.0 |
% |
10.1021/jm00122a011 |
| Canis lupus familiaris |
Canis familiaris |
Change |
11.0 |
% |
10.1021/jm00383a006 |
| Canis lupus familiaris |
Canis familiaris |
Change |
12.0 |
% |
10.1021/jm00391a026 |
| Canis lupus familiaris |
Canis familiaris |
Change |
19.0 |
% |
10.1021/jm00163a052 |
| Canis lupus familiaris |
Canis familiaris |
Change |
32.0 |
% |
10.1021/jm00122a011 |
| Canis lupus familiaris |
Canis familiaris |
Change |
85.0 |
% |
10.1021/jm00122a011 |
| Canis lupus familiaris |
Canis familiaris |
Change |
134.0 |
% |
10.1021/jm00391a026 |
| Canis lupus familiaris |
Canis familiaris |
Change |
165.0 |
% |
10.1021/jm00122a011 |
| Canis lupus familiaris |
Canis familiaris |
Change of CF |
6.5 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of CF |
22.4 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of CF |
79.7 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of CO |
1.9 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of CO |
15.6 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of CO |
36.5 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of DBP |
-14.1 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of DBP |
-4.7 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of DBP |
-4.1 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of HR |
1.2 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of HR |
3.8 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of HR |
8.1 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of SBP |
-5.5 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of SBP |
-5.0 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Change of SBP |
-2.7 |
% |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
Decrease in MAP |
nan |
None |
10.1021/jm00388a014 |
| Canis lupus familiaris |
Canis familiaris |
DOSE |
0.389 |
mg.kg-1 |
10.1021/jm00148a006 |
| Canis lupus familiaris |
Canis familiaris |
dP/dt |
6.7 |
max |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
dP/dt |
22.3 |
max |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
dP/dt |
54.8 |
max |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
ED15 |
200.0 |
ug |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
ED30 |
472.0 |
ug kg-1 |
10.1021/jm00390a007 |
| Canis lupus familiaris |
Canis familiaris |
ED50 |
0.38 |
mg.kg-1 |
10.1021/jm00391a026 |
| Canis lupus familiaris |
Canis familiaris |
ED50 |
0.389 |
mg.kg-1 |
10.1021/jm00388a014 |
| Canis lupus familiaris |
Canis familiaris |
ED50 |
0.389 |
mg.kg-1 |
10.1021/jm00394a005 |
| Canis lupus familiaris |
Canis familiaris |
ED50 |
0.39 |
mg.kg-1 |
10.1021/jm00394a006 |
| Canis lupus familiaris |
Canis familiaris |
ED50 |
1.3 |
mg.kg-1 |
10.1021/jm00383a006 |
| Canis lupus familiaris |
Canis familiaris |
ED50 |
1.891 |
mg.kg-1 |
10.1021/jm00155a009 |
| Canis lupus familiaris |
Canis familiaris |
Heart rate |
13.0 |
beats min-1 |
10.1021/jm00155a009 |
| Canis lupus familiaris |
Canis familiaris |
Increase |
6.0 |
% |
10.1021/jm00148a006 |
| Canis lupus familiaris |
Canis familiaris |
Increase |
18.0 |
% |
10.1021/jm00148a006 |
| Canis lupus familiaris |
Canis familiaris |
Increase |
23.0 |
% |
10.1021/jm00148a006 |
| Canis lupus familiaris |
Canis familiaris |
Increase |
45.0 |
% |
10.1021/jm00148a006 |
| Canis lupus familiaris |
Canis familiaris |
Increase in HR |
nan |
None |
10.1021/jm00388a014 |
| Canis lupus familiaris |
Canis familiaris |
MAP |
16.0 |
beats min-1 |
10.1021/jm00155a009 |
| Canis lupus familiaris |
Canis familiaris |
Mean ED50 |
0.389 |
mg kg-1 |
10.1021/jm00375a001 |
| Canis lupus familiaris |
Canis familiaris |
Ratio |
0.23 |
None |
10.1021/jm00122a011 |
| Cavia porcellus |
Cavia porcellus |
EC20 |
62.0 |
uM |
10.1021/jm970089s |
| Cavia porcellus |
Cavia porcellus |
EC50 |
7400.0 |
nM |
10.1021/jm970089s |
| Cavia porcellus |
Cavia porcellus |
Increase |
4.5 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
4.62 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
6.49 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
7.08 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
8.85 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
11.52 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
15.68 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
17.52 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
17.92 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
23.34 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
23.92 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
24.11 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
25.3 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
26.3 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
27.0 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
28.81 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
30.69 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Increase |
34.6 |
% |
10.1021/jm00069a005 |
| Cavia porcellus |
Cavia porcellus |
Inhibition |
49.0 |
% |
10.1021/jm00114a010 |
| Cavia porcellus |
Cavia porcellus |
Inhibition |
100.0 |
% |
10.1021/jm00114a010 |
| Cavia porcellus |
Cavia porcellus |
Variation |
0.0 |
% |
10.1021/jm9508649 |
| Cavia porcellus |
Cavia porcellus |
Variation |
0.52 |
% |
10.1021/jm9508649 |
| Cavia porcellus |
Cavia porcellus |
Variation |
1.5 |
% |
10.1021/jm9508649 |
| Cavia porcellus |
Cavia porcellus |
Variation |
4.5 |
% |
10.1021/jm9508649 |
| Cavia porcellus |
Cavia porcellus |
Variation |
6.25 |
% |
10.1021/jm9508649 |
| Cavia porcellus |
Cavia porcellus |
Variation |
7.2 |
% |
10.1021/jm9508649 |
| Cavia porcellus |
Cavia porcellus |
Variation |
9.87 |
% |
10.1021/jm9508649 |
| Cavia porcellus |
Cavia porcellus |
Variation |
10.22 |
% |
10.1021/jm9508649 |
| Cavia porcellus |
Cavia porcellus |
Variation |
19.03 |
% |
10.1021/jm9508649 |
| Cavia porcellus |
Cavia porcellus |
Variation |
23.12 |
% |
10.1021/jm9508649 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cryptosporidium parvum |
Cryptosporidium parvum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Equus caballus |
Ferritin light chain |
Potency |
281.8 |
nM |
None |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Inhibition |
5.0 |
% |
10.1021/jm030191r |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Potency |
44668.4 |
nM |
None |
| Felis catus |
Felis catus |
Control |
143.0 |
% |
10.1021/jm00383a006 |
| Felis catus |
Felis catus |
Control |
190.0 |
% |
10.1021/jm00383a006 |
| Felis catus |
Felis catus |
Increase |
50.0 |
% |
10.1021/jm00158a022 |
| Felis catus |
Felis catus |
Response ratio |
0.61 |
None |
10.1021/jm00383a006 |
| Felis catus |
Felis catus |
Response ratio |
1.25 |
None |
10.1021/jm00383a006 |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
1774.1 |
nM |
None |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
3539.7 |
nM |
None |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
3971.6 |
nM |
None |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5/Perilipin-5 |
IC50 |
78816.0 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
2300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-galactosidase A |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Arachidonate 12-lipoxygenase |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
7307.8 |
nM |
None |
| Homo sapiens |
ATP-dependent DNA helicase Q1 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
ATP-dependent DNA helicase Q1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Aurora kinase B/Inner centromere protein |
Ki |
59300.0 |
nM |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Inotropic effect |
57.0 |
None |
10.1021/jm00385a001 |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bile salt export pump |
IC50 |
135000.0 |
nM |
10.1093/toxsci/kfq269 |
| Homo sapiens |
Bile salt export pump |
IC50 |
370800.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bloom syndrome protein |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Casein kinase I delta |
Inhibition |
40.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Caspase-1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Chymotrypsin C |
Inhibition |
5.0 |
% |
10.1021/jm030191r |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
15848.93 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
5011.87 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
12589.25 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
12589.25 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
3162.28 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
DNA polymerase eta |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
DNA polymerase iota |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Dual specificity protein kinase TTK |
Inhibition |
50.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Dual specificity protein kinase TTK |
Ki |
80800.0 |
nM |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Geminin |
Potency |
51.7 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glutaminase kidney isoform, mitochondrial |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Inhibition |
9.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
GTP-binding nuclear protein Ran/Importin subunit beta-1/Snurportin-1 |
Potency |
20596.2 |
nM |
None |
| Homo sapiens |
Hepatocyte growth factor receptor |
Inhibition |
0.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
HepG2 |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-0.63 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
4.59 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
Activity |
0.93 |
% |
10.1016/j.ejmech.2009.11.034 |
| Homo sapiens |
Homo sapiens |
CL |
8.9 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
3.1 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
5.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Fabs |
93.0 |
% |
10.1124/dmd.110.034629 |
| Homo sapiens |
Homo sapiens |
IC50 |
15000.0 |
nM |
10.1021/jm00122a011 |
| Homo sapiens |
Homo sapiens |
IC50 |
50000.0 |
nM |
10.1021/jm00122a011 |
| Homo sapiens |
Homo sapiens |
IC50 |
250000.0 |
nM |
10.1021/jm00122a011 |
| Homo sapiens |
Homo sapiens |
IC50 |
500000.0 |
nM |
10.1021/jm00122a011 |
| Homo sapiens |
Huntingtin |
Potency |
501.2 |
nM |
None |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Importin subunit beta-1/Snurportin-1 |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Insulin receptor |
Inhibition |
1.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
1122.0 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Mannose-6-phosphate isomerase |
IC50 |
50000.0 |
nM |
None |
| Homo sapiens |
MAP kinase-activated protein kinase 2 |
Inhibition |
1.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
MAP kinase-activated protein kinase 5 |
Inhibition |
0.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Inhibition |
0.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Inhibition |
0.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Inhibition |
0.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
1412.5 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
1995.3 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
3548.1 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
4466.8 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscleblind-like protein 1 |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Perilipin-1/ABHD5 |
IC50 |
79476.0 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 1 |
IC50 |
300000.0 |
nM |
10.1021/jm970089s |
| Homo sapiens |
Phosphodiesterase 1 |
IC50 |
1000000.0 |
nM |
10.1021/jm00394a005 |
| Homo sapiens |
Phosphodiesterase 1 |
IC50 |
1000000.0 |
nM |
10.1021/jm00394a006 |
| Homo sapiens |
Phosphodiesterase 1 |
IC50 |
1000000.0 |
nM |
10.1021/jm50001a001 |
| Homo sapiens |
Phosphodiesterase 2A |
IC50 |
580000.0 |
nM |
10.1021/jm00394a005 |
| Homo sapiens |
Phosphodiesterase 2A |
IC50 |
580000.0 |
nM |
10.1021/jm00394a006 |
| Homo sapiens |
Phosphodiesterase 2A |
IC50 |
700000.0 |
nM |
10.1021/jm00394a006 |
| Homo sapiens |
Phosphodiesterase 2A |
IC50 |
700000.0 |
nM |
10.1021/jm50001a001 |
| Homo sapiens |
Phosphodiesterase 2A |
IC50 |
720000.0 |
nM |
10.1021/jm00394a005 |
| Homo sapiens |
Phosphodiesterase 3 |
IC50 |
16000.0 |
nM |
10.1021/jm00122a011 |
| Homo sapiens |
Phosphodiesterase 3 |
IC50 |
16000.0 |
nM |
10.1021/jm970089s |
| Homo sapiens |
Phosphodiesterase 3 |
IC50 |
16700.0 |
nM |
10.1021/acsmedchemlett.3c00092 |
| Homo sapiens |
Phosphodiesterase 3 |
IC50 |
28000.0 |
nM |
10.1021/jm00028a007 |
| Homo sapiens |
Phosphodiesterase 3 |
IC50 |
35000.0 |
nM |
10.1021/jm50001a001 |
| Homo sapiens |
Phosphodiesterase 3 |
IC50 |
46000.0 |
nM |
10.1021/jm00394a006 |
| Homo sapiens |
Phosphodiesterase 3 |
IC50 |
50000.0 |
nM |
10.1021/jm00375a001 |
| Homo sapiens |
Phosphodiesterase 3 |
IC50 |
50000.0 |
nM |
10.1021/jm00394a005 |
| Homo sapiens |
Phosphodiesterase 3 |
IC50 |
60000.0 |
nM |
10.1021/jm00391a026 |
| Homo sapiens |
Phosphodiesterase 3 |
IC50 |
150000.0 |
nM |
10.1021/jm00155a009 |
| Homo sapiens |
Phosphodiesterase 3 |
Ratio |
3.1 |
None |
10.1021/jm00122a011 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
22934.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4 |
IC50 |
41000.0 |
nM |
10.1021/jm00163a052 |
| Homo sapiens |
Phosphodiesterase 4 |
IC50 |
101000.0 |
nM |
10.1021/jm970089s |
| Homo sapiens |
Phosphodiesterase 4 |
IC50 |
126000.0 |
nM |
10.1021/jm00114a010 |
| Homo sapiens |
Phosphodiesterase 4 |
IC50 |
150000.0 |
nM |
10.1021/jm00163a052 |
| Homo sapiens |
Phosphodiesterase 4 |
Inhibition |
24.0 |
% |
10.1021/jm00163a052 |
| Homo sapiens |
Phosphodiesterase 4 |
Inhibition |
52.0 |
% |
10.1021/jm00114a010 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase; PDE3 & PDE4 |
IC50 |
4800.0 |
nM |
10.1021/jm00388a014 |
| Homo sapiens |
Phosphodiesterase; PDE3 & PDE4 |
PDE inhibition |
24.0 |
None |
10.1021/jm00385a001 |
| Homo sapiens |
Phosphodiesterase; PDE3 & PDE4 |
PDE inhibition |
56.0 |
None |
10.1021/jm00385a001 |
| Homo sapiens |
Phosphodiesterase; PDE3 & PDE4 |
PDE inhibition |
57.0 |
None |
10.1021/jm00385a001 |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
316.2 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
20000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Protein kinase C zeta |
Inhibition |
50.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Rap guanine nucleotide exchange factor 3 |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Ribosomal protein S6 kinase alpha 1 |
Inhibition |
27.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Ribosomal protein S6 kinase alpha 5 |
Inhibition |
27.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Serine hydroxymethyltransferase, mitochondrial |
Inhibition |
92.3 |
% |
None |
| Homo sapiens |
Serine/threonine-protein kinase AKT |
Inhibition |
12.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Serine/threonine-protein kinase AKT2 |
Inhibition |
0.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Inhibition |
0.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Ki |
393900.0 |
nM |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-B |
Inhibition |
43.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Serine/threonine-protein kinase Chk1 |
Inhibition |
68.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Serine/threonine-protein kinase Chk2 |
Inhibition |
0.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Serine/threonine-protein kinase D2 |
Inhibition |
0.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Serine/threonine-protein kinase PLK1 |
Potency |
29934.9 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Survival motor neuron protein |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase ABL |
Inhibition |
11.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Inhibition |
10.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase ITK/TSK |
Inhibition |
nan |
% |
10.1021/jm101499u |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Inhibition |
6.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase Lyn |
Inhibition |
18.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Tyrosine-protein kinase SRC |
Inhibition |
12.0 |
% |
10.1016/j.bmc.2018.04.033 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
16360.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
19952.6 |
nM |
None |
| Leishmania amazonensis |
Leishmania amazonensis |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania infantum |
Leishmania infantum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania major |
Leishmania major |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania mexicana |
Leishmania mexicana |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
31622.8 |
nM |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
13115.4 |
nM |
None |
| Pneumocystis carinii |
Pneumocystis carinii |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Aorta |
EC50 |
17000.0 |
nM |
10.1016/j.ejmech.2014.05.052 |
| Rattus norvegicus |
Aorta |
EC50 |
28000.0 |
nM |
10.1016/j.ejmech.2014.05.052 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
50118.7 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
79432.8 |
nM |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Schistosoma mansoni |
Thioredoxin glutathione reductase |
Potency |
39810.7 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-11.61 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
13.44 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.2162 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-39.64 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.27 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.08 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.1296 |
None |
10.1101/2020.04.03.023846 |
| Sus scrofa |
Malate dehydrogenase mitochondrial |
Inhibition |
5.0 |
% |
10.1021/jm030191r |
| Toxoplasma gondii |
Toxoplasma gondii |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
23934.1 |
nM |
None |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei brucei (strain 927/4 GUTat10.1) |
Putative uncharacterized protein |
Potency |
50118.7 |
nM |
None |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| None |
ADMET |
CL |
8.9 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
delta logD |
-0.02 |
None |
10.1021/jm0000564 |
| None |
ADMET |
F |
80.0 |
% |
10.1021/jm0000564 |
| None |
ADMET |
MRT |
2.4 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Papp |
4.3 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
7.5 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
13.3 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
14.4 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
16.6 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
19.4 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
-43.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
-23.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
0.7 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
1.4 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
3.3 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
22.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
30.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
52.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
66.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
T1/2 |
2.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
1.3 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
2.2 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
2.2 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
6.6 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
4.4 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
Fu |
0.89 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
9.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
33.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| None |
No relevant target |
LogD |
-0.72 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
LogP |
2.66 |
None |
10.1021/jm00069a005 |
| None |
No relevant target |
pKa |
5.2 |
None |
10.1021/jm0000564 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
Ac50 |
0.631 |
uM |
None |
| None |
Unchecked |
Ac50 |
0.8913 |
uM |
None |
| None |
Unchecked |
Ac50 |
2.818 |
uM |
None |
| None |
Unchecked |
Ac50 |
3.162 |
uM |
None |
| None |
Unchecked |
Ac50 |
5.012 |
uM |
None |
| None |
Unchecked |
AC50 |
631.0 |
nM |
None |
| None |
Unchecked |
AC50 |
891.3 |
nM |
None |
| None |
Unchecked |
AC50 |
2820.0 |
nM |
None |
| None |
Unchecked |
AC50 |
3162.3 |
nM |
None |
| None |
Unchecked |
AC50 |
5011.9 |
nM |
None |
| None |
Unchecked |
Activity |
1.4 |
uM |
10.1021/jm00011a018 |
| None |
Unchecked |
Hepatotoxicity (acute) |
6.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
50000.0 |
nM |
10.1021/jm00122a011 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
68.0 |
% |
10.1016/j.bmc.2018.04.033 |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
3981.1 |
nM |
None |
| None |
Unchecked |
Ratio |
50.0 |
None |
10.1021/jm00394a005 |
| None |
Unchecked |
Ratio |
63.8 |
None |
10.1021/jm00394a005 |